CD4 and chronic obstructive pulmonary disease: For example, the use of a LAMA, such as tiotropium, as an add-on therapy to a LABA, such as formoterol, has been shown to reduce the percentage of CD4+CD25+ regulatory T cells and lower HLA-DR expression in airway lymphocytes of patients with COPD [35].